Alembic Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE901L01018
  • NSEID: APLLTD
  • BSEID: 533573
INR
850.35
4.65 (0.55%)
BSENSE

Sep 21, 03:30 PM

BSE+NSE Vol: 2.57 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryAlembic Pharma VS Pharmaceuticals & Biotechnology
 
1D
0.55%
0.76%
1W
4.7%
0.1%
1M
3.64%
-3.46%
YTD
0.25%
-12.16%
1Y
-11.16%
-9.4%
3Y
11.06%
13.03%
5Y
8.84%
26.87%
10Y
29.71%
162.59%
  • Stock Absolute Returns
  • India SENSEXAbsolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (1.42%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
11.64%
1.54%
13.18%
6 Months
25.6%
1.78%
27.38%
1 Year
-11.16%
1.35%
-9.81%
2 Years
-23.76%
1.85%
-21.91%
3 Years
11.06%
4.47%
15.53%
4 Years
40.33%
7.30%
47.63%
5 Years
8.84%
6.41%
15.25%

Latest dividend: 12 per share ex-dividend date: Jul-29-2026

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Inconsistent Performance

Alembic Pharmaceuticals Ltd. has not been a consistent performer in the YTD and longer periods

3
Quartile
quartile-3
QTD
3.25%
3
Quartile
quartile-3
Mar-Jun
24.43%
3
Quartile
quartile-3
Dec-Mar
-21.97%
3
Quartile
quartile-3
YTD
-10.49%
2
Quartile
quartile-2
2025
-20.3%
4
Quartile
quartile-4
2024
40.09%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry stock-summary
Inconsistent Performance

Alembic Pharmaceuticals Ltd. has not been a consistent performer in the YTD and longer periods

3
Quartile
quartile-3
QTD
3.25%
3
Quartile
quartile-3
Mar-Jun
24.43%
3
Quartile
quartile-3
Dec-Mar
-21.97%
3
Quartile
quartile-3
YTD
-10.49%
3
Quartile
quartile-3
2025
-20.3%
2
Quartile
quartile-2
2024
40.09%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap stock-summary
Inconsistent Performance

Alembic Pharmaceuticals Ltd. has not been a consistent performer in the YTD and longer periods

2
Quartile
quartile-2
QTD
3.25%
3
Quartile
quartile-3
Mar-Jun
24.43%
3
Quartile
quartile-3
Dec-Mar
-21.97%
3
Quartile
quartile-3
YTD
-10.49%
3
Quartile
quartile-3
2025
-20.3%
2
Quartile
quartile-2
2024
40.09%
Click on any of the quartiles for detailed breakdown
stock-summaryRisk Adjusted Returns v/s India SENSEX
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available